Rafael Guayta

Learn More
BACKGROUND COPD case finding is currently recommended at primary and tertiary care levels only. AIM To evaluate the feasibility of a community pharmacy program for COPD case finding in high-risk customers by means of spirometry. METHODS Pilot cross-sectional descriptive study in 13 urban community pharmacies in Barcelona, Spain, from April to May 2007.(More)
BACKGROUND & AIMS The latest generation of fecal immunochemical tests (FIT) allows for quantitation of hemoglobin in feces, allowing for selection of optimal cut-off concentrations. We investigated whether individuals with positive results from quantitative FITs, in combination with other factors, could be identified as being at greatest risk for advanced(More)
BACKGROUND Community pharmacies (CP) have access to subjects at high-risk of suffering Chronic Obstructive Pulmonary Disease (COPD). We investigated if a COPD case finding program in CP could be a new strategy to reduce COPD underdiagnosis. METHODS Prospective, cross-sectional, descriptive, uncontrolled, remotely supported study in 100 CP in Barcelona,(More)
BACKGROUND We aimed at describing the smoking prevalence trend among the Catalan population (Spain) from 1982 to 1998, based on a gender perspective analysis. SUBJECTS AND METHOD Data obtained from the surveys carried out by the Catalan Department of Health in 1982, 1986, 1990, 1994 and 1998 were analysed. Variables included were those related to smoking(More)
BACKGROUND AND OBJECTIVE Population-based bowel screening programmes with faecal occult blood (FOB) tests need to achieve high uptake rates and offer quality services. We invited participants in the Barcelona Programme to complete a satisfaction survey, in order to explore factors influencing uptake and respondents' opinion and satisfaction with each step(More)
BACKGROUND Common low-penetrance genetic variants have been consistently associated with colorectal cancer risk. AIM To determine if these genetic variants are associated also with adenoma susceptibility and may improve selection of patients with increased risk for advanced adenomas and/or multiplicity (≥ 3 adenomas). METHODS We selected 1,326 patients(More)
  • 1